SeaStar Medical Holding Corporation Announces $8 Million Public Offering to Support Corporate Initiatives

Reuters
06-23
<a href="https://laohu8.com/S/ICU">SeaStar Medical Holding Corporation</a> Announces $8 Million Public Offering to Support Corporate Initiatives

SeaStar Medical Holding Corporation, a commercial-stage healthcare company focused on treatments for critically ill patients, announced the pricing of a public offering. The company plans to offer 6,153,847 shares of its common stock and accompanying Series A and Series B warrants at a combined price of $0.65 per share. The offering is expected to generate approximately $4 million in gross proceeds initially, with the potential for an additional $4 million if the Series B short-term warrants are fully exercised. H.C. Wainwright & Co. is serving as the exclusive placement agent for this offering. The proceeds will be used for general corporate purposes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Seastar Medical Holding Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950170-25-088707), on June 23, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10